Atrovastatin for Preventing Atrial Fibrillation Following Open Cardiac Valve Repair
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the investigation is to determine whether Atrovastatin as anti-inflammatory
agent can be effective in preventing from atrial fibrillation incidence in patients whom
undergone open cardiac surgery for their heart valve repair.